Research Paper Volume 15, Issue 20 pp 11369—11388
Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer
Figure 4. Construction of a prognostic risk model for PCa according to integrin αvβ3/α6β1. (A–C) Kaplan-Meier analysis for biochemical recurrence, PFS and OS in the two risk groups. (D–F) ROC analysis was performed to validate the predictive power for biochemical recurrence, PFS and OS of PCa patients in our model. (G, H) Forest maps of univariate and multivariate analyses for risk score in our model.